共 50 条
- [21] Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis Hepatology International, 2020, 14 : 765 - 775
- [27] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer Drug Safety, 2019, 42 : 281 - 294